The popular blog “Drug and Device Law,” which reports on significant “topics that arise in the defense of pharmaceutical and medical device product liability litigation,” has chosen the Alabama Supreme Court’s decision in AstraZeneca LP v. State of Alabama, __ So. 3d ___, 2009 WL 3335904 (Ala. Oct. 16, 2009), as its most significant case of the year. In its decision, the Court reversed fraud judgments totaling some $275 million against pharmaceutical manufacturers AstraZeneca, GlaxoSmithKline, and Novartis, and rendered judgment for all three defendants. Bradley Arant lawyers Kevin Newsom, Marc James Ayers, and Andrew Brasher represented GlaxoSmithKline in the case. For Drug and Device Law’s full report, click here.